CWGCX
Price
$67.06
Change
-$0.16 (-0.24%)
Updated
Sep 20 closing price
FIQQX
Price
$22.77
Change
-$0.05 (-0.22%)
Updated
Sep 20 closing price
Ad is loading...

CWGCX vs FIQQX

Header iconCWGCX vs FIQQX Comparison
Open Charts CWGCX vs FIQQXBanner chart's image
American Funds Capital World Gr&Inc C
Price$67.06
Change-$0.16 (-0.24%)
VolumeN/A
CapitalizationN/A
Fidelity Advisor Global Equity Inc Z
Price$22.77
Change-$0.05 (-0.22%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CWGCX vs FIQQX Comparison Chart
Loading...
VS
CWGCX vs. FIQQX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a StrongBuy and FIQQX is a Buy.

FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 128B vs. FIQQX (101M). FIQQX pays higher dividends than CWGCX: FIQQX (1.19) vs CWGCX (1.04). CWGCX was incepted earlier than FIQQX: CWGCX (24 years) vs FIQQX (6 years). CWGCX is a more actively managed with annual turnover of: 27.00 vs. FIQQX (25.00). FIQQX has a lower initial minimum investment than CWGCX: FIQQX (0) vs CWGCX (250). FIQQX annual gain was more profitable for investors over the last year : 20.77 vs. CWGCX (19.12). FIQQX return over 5 years is better than : 55.55 vs. CWGCX (40.68).
CWGCXFIQQXCWGCX / FIQQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years6 years-
Gain YTD11.85613.80086%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets128B101M126,733%
Annual Yield % from dividends1.041.1988%
Returns for 1 year19.1220.7792%
Returns for 3 years4.4111.8637%
Returns for 5 years40.6855.5573%
Returns for 10 years45.01N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNFT4.340.11
+2.60%
Genfit SA
CCL18.360.33
+1.83%
Carnival Corp
IMNM15.500.10
+0.65%
Immunome
PGNY24.44-0.38
-1.53%
Progyny
MTNB3.52-0.07
-2.00%
Matinas Biopharma Holdings Inc